| FDA New, GMP Do Clinical Phase II, III Intermediates GMP Custom synthesis, Full Document R&D Center: 8000 sq, More than 100 hoods Pilot Plant: 20000sq, 40 reactors from 5-200L Manufacturing Site: 800000sq, 40 reactors from 100-5000L Web: www.eosmedchem.com Email: info@eosmedchem.com; eosmedchem@gmail.com This is my R&D youtube: https://youtu.be/r5cJdXKNXHk |
| Selisistat, 49843-98-3, Selisistat Intermediate 1655-07-8, stock 755.9g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
| Selisistat, 49843-98-3, Selisistat Intermediate 30132-23-1, stock 811.3g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |
| Selisistat, 49843-98-3, Selisistat Intermediate 106-47-8, stock 766.3g, white powder, assay by HPLC 99.2%, HNMR, LCMS we supply. |
| Selisistat, 49843-98-3, Selisistat Intermediate 49844-36-2, stock 298.7g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply. |
| Selisistat, 49843-98-3, Selisistat Intermediate /, stock 880.4g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
